Lv7
3310 积分 2022-07-20 加入
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
18天前
已完结
Extended follow-up of recurrent glioblastoma patients treated with boron neutron capture therapy (BNCT): Long-term survival from a Phase II trial (JG002) using Cyclotron Neutron Source and Boronophenylalanine
18天前
已完结
How to improve R&D productivity: the pharmaceutical industry's grand challenge
1个月前
已完结
Costs of Drug Development and Research and Development Intensity in the US, 2000-2018
2个月前
已完结
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
2个月前
已完结
Drug repurposing: progress, challenges and recommendations
2个月前
已完结
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race
3个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
4个月前
已完结
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
4个月前
已完结
皖公网安备34019202002308
